It's the drug I'm interested in, not the share structure at this point (good or bad). If the drug does what it says it does, one of the big boys is going to scoop up GNTA in a heartbeat.
No one wants to miss out on that happening. Not even you, griff.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.